InterVenn BioSciences

MultivisionDx

This company develops AI-powered spatial biology platforms and diagnostic tests for clinicians and researchers to improve treatment decisions for solid cancer patients.

Glycanostics

This digital health company develops non-invasive liquid biopsy tests for early-stage cancer detection, serving clinical laboratories, hospitals and oncology professionals.

Artera

This company develops artificial intelligence tests that predict cancer outcomes and treatment benefits for clinicians and their patients.

20/20 BioLabs

This company develops AI-powered blood tests for the early detection and prevention of cancers and chronic diseases for individuals and healthcare providers.

GLX Analytix

This company develops blood-based diagnostic and monitoring tests for clinicians to manage neurodegenerative, autoimmune and neuropsychiatric diseases using glycocalyx biomarkers and artificial intelligence.

Hepta Bio

This company develops AI-powered blood tests for chronic liver disease diagnostics to assist clinicians and pharmaceutical companies with patient identification and monitoring.

Preview Health

This company develops an artificial intelligence molecular profiling platform to help pharmaceutical companies and clinicians detect diseases and evaluate drug responses through biological samples.

Waiv

This company develops artificial intelligence diagnostic tests and digital pathology software for oncology laboratories and healthcare providers to improve cancer patient treatment decisions.